Ending the HIV epidemic in the United States once seemed impossible. But today, it’s within reach. Employers can play a critical role in helping to ensure prevention and treatment tools reach those who need them the most.
Avalere, BioStax Corp., Greater Phoenix Equality Chamber of Commerce, Mercer, Michael Mazzocco Events, mistr, Molecular Testing Labs, Paramount Pictures, Pfizer, and Specialized Occupational Therapy Services LLC are the latest among dozens of companies committing to accelerating progress to end HIV in the U.S. by joining U.S. Business Action to End HIV ahead of National HIV Testing Day (June 27).
Ending the HIV epidemic in the United States once seemed impossible. But today, it’s within reach. We now have access to the most powerful HIV prevention and treatment tools in history. Employers can play a critical role in helping to ensure they reach those who need them the most.
Taking Action on National HIV Testing Day
National HIV Testing Day is a landmark day observed each year on June 27 to raise awareness about the importance of HIV testing and early diagnosis of HIV. Left untreated, HIV can cause serious harm to one’s health, compromising the ability to work and increasing healthcare costs for employers. An estimated one in seven people live with HIV in the U.S. and don’t know it.
To help support companies leverage the urgency of National HIV Testing Day and take action on HIV, the Health Action Alliance has released a playbook designed specifically for employers with six actions you can take to encourage HIV testing, combat stigma and promote a supportive environment.
In addition, members of the U.S. Business Action to End HIV are leading by example as they ramp up their efforts around National HIV Testing Day.
As National HIV Testing Day approaches, consider what steps your organization can take to help employees prioritize and protect their health on June 27 and beyond.
Interested in doing more? Consider joining U.S. Business Action to End HIV, founded in 2022 by the Health Action Alliance, with support from ViiV Healthcare, to enlist employers in the fight to end HIV in the U.S. by 2030.
By joining the coalition, companies join a community of like-minded organizations who are interested in leveraging their resources and influence to change the trajectory of HIV in the U.S. They also get access to free employer resources - like Ending the HIV Epidemic - A Guide for Employers, communications tools, educational events, training/coaching and technical support for building local public-private partnerships in communities most affected by HIV.
U.S. Business Action to End HIV is excited to have nine distinguished leaders serving on the HIV Leadership Advisory Council, which guides the work of the coalition. They include:
These members, who represent a range of sectors, experience and regions, support the coalition and ensure the most current science and best practices inform the priorities of the U.S. Business Action to End HIV.
The growing coalition is developed in partnership with the National LGBT Chamber of Commerce with funding from Gilead Sciences and ViiV Healthcare.
To learn more about the U.S. Business Action to End HIV visit healthaction.org/endhiv or email endHIV@healthaction.org.
Sign up for our newsletter to keep updated on HAA’s latest initiatives, insights and recommendations, and be first to receive new resources and event invitations.
Sign up